But a fourth wave of cancer therapy is about to break.

This means that miR-22 could be a potential target for cancer therapies.

Eligible patients will be those for whom all cancer therapy has failed and who have been given less than 90 days to live.

His focus was on developing and testing new cancer therapies.

It is also a promising drug in many cancer therapies.

The cause was complications related to cancer therapy, the foundation said.

This may lead to a more effective and personalized cancer therapy.

While in the hospital, sleep disorders may make it hard for the patient to continue with cancer therapy.

They are one of the most successful targeted cancer therapies that have been tried.

Another $800 million would pay for trials of cancer therapies among Medicare patients.